Objective: To determine the diagnostic accuracy of Doppler ultrasonography in predicting presence of esophageal varices in patients with hepatitis-C induced cirrhosis. Study Design: Descriptive analytical study. Place and Duration of Study: Department of Radiology, Jinnah Hospital, Lahore, from May 2016 to October 2016. Methodology: Patients aged 15-70 years, who presented with cirrhosis and proved to be cirrhosis caused by Hepatitis-C of any gender and duration of disease more than 6 months, were included. Patients with hepatocelullar carcinoma or portal vein thrombosis, having received treatment for esophageal varices, and unwilling to undergo endoscopy were excluded. All the patients then underwent Doppler ultrasonography to calculate splenoportal index and findings were correlated with endoscopy findings. Results: Out of 200 patients, 137 (68.50%) were males and 63 (31.50%) were females. In Doppler ultrasonography positive patients, 113 were true positive and 8 were false positive. Overall sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of Doppler ultrasonography in predicting presence of esophageal varices was 88.98%, 89.04%, 93.00%, 82.28% and 89.00%, respectively. Conclusion: Doppler ultrasonography is the non-invasive modality of choice with high diagnostic accuracy in predicting presence of esophageal varices in hepatitis-C induced cirrhosis.
INTRODUCTION
Cirrhosis was the tenth leading cause of death in lowermiddle income countries in 2012. 1 The leading cause of cirrhosis in Pakistan is hepatitis-C infection, accounting for 52-61% of cirrhosis cases. 2 Out of every 100 people infected with HCV, between 5 and 20 develop cirrhosis.
Esophageal varix formation, resulting from portal hypertension, is a common major complication of cirrhosis and the most common clinical manifestation. 3 Variceal development starts when hepatic venous pressure gradient reaches 10 mmHg. 4 De novo formation of varices occurs at a rate of 7-8% per year. 5 In Pakistan, the prevalence of esophageal varices is 65%. 2 Presence of varices correlates with the severity of liver disease -40% of patients with compensated and 60% with decompensated cirrhosis have esophageal varices. 6 Varices develop and increase in size before eventually rupturing and bleeding, occurring in upto 30% of cirrhotic patients, 7 and associated with a mortality rate of 16-24%. 8 Infact, the mortality rate from the first episode of bleed is alarmingly high at 40-60% and only 30-40% of patients who do not receive treatment survive 2 years after the initiation of bleeding. 9 Therefore, early detection of esophageal varices is imperative for reducing morbidity and mortality.
Endoscopy remains the gold standard for the diagnosis of esophageal varices and is also used therapeutically. Screening endoscopy for varices is recommended in all patients with cirrhosis. However, these recommendations are not a result of evidence-based data. 10 It has not yet been proven to be cost-effective for patients with compensated cirrhosis. 11 Doppler ultrasonography has been suggested as an ideal tool for diagnosing portal hypertension. 12 A number of studies have been conducted to assess the use of various Doppler ultrasonography indices for prediction of esophageal varices with conflicting results. 13, 14 Potentially useful indices studied include spleno-portal index, 6,10 hepatic congestion index, and portal vein velocity. 13 There is a dearth of local data available on this subject, with only one study, 15 done in Pakistani population regarding the use of Doppler ultrasonography for predicting esophageal varices in cirrhotic patients. Therefore, this study would add a non-invasive alternate for detecting complications of a relatively common disease in local population. The study was conducted to determine the accuracy of ultrasound indices in Figure I ).
DISCUSSION
Esophageal varices tend to be a common complication of cirrhosis, estimated to occur in upto 50-61% of these patients. 16 Although such patients can have bleeding episodes due to various causes, hematemesis due to these varices is the foremost among them. This bleeding can be life-threatening and once it occurs, chances of another episode increase dramatically; the rate of rebleeding has been reported to be as high as 70% with Diagnostic accuracy of doppler ultrasonography in predicting presence of esophageal varices in patients with hepatitis-C induced cirrhosis one-third of such episodes proving to be fatal. Therefore, the interest in developing a tool for early diagnosis of esophageal varices comes as no surprise.
Upper GI endoscopy is currently regarded as the gold standard for diagnosis of esophageal varices. Therefore, periodic screening endoscopy is currently recommended to all patients with established cirrhosis. 3 Endoscopy not only serves as a diagnostic tool but also serves therapeutic options in the form of sclerotherapy and band ligation. However, many patients screened for esophageal varices do not have them. Therefore, endoscopy in these patients carries a useless burden of stress and financial burden on patients as well as unnecessary burden on health facilities. 17 Moreover, the invasive nature of the process leads to low compliance, 18 and can contribute to infections due to disruption of normal barriers. 19 A non-invasive tool, which can serve the same purpose, is therefore, the need of the hour.
A number of biochemical and imaging parameters have been studied till date, to predict the presence of esophageal varices in cirrhotic patients. 20 Most of the studied imaging parameters utilise ultrasonographically measured indices such as splenic bipolar diameter, portal vein diameter, splenic vein diameter, spleno-portal index, hepatic congestion index, portal vein velocity and resistive indices of hepatic artery, splenic artery, renal artery, and superior mesenteric artery. In fact, ultrasonography offers a number of advantages, it is noninvasive, inexpensive and widely available. In this study, the diagnostic accuracy of one of the ultrasonographically determined indices, i.e. spleno-portal index was assessed for predicting the presence of esophageal varices in patients having cirrhosis induced by hepatitis-C, taking endoscopy as gold standard.
In this study, sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of Doppler ultrasonography in predicting presence of esophageal varices were 88.98%, 89.04%, 95.00%, 82.28% and 89.00%, respectively. In another study conducted by Liu et al., 10 a number of parameters were evaluated for predicting the presence of esophageal varices cirrhosis. The study concluded that spleno-portal index was the best among these parameters having sensitivity of 92%, specificity of 93%, positive predictive value of 91%, and negative predictive value of 94% for esophageal varices. They reported a high diagnostic accuracy of 92-94% for this index.
A similar study was conducted locally in province of Sindh which studied splenoportal index as well as platelet count to splenic diameter ratio for similar purposes. 15 This study reported sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of 75%, 65.1%, 77.3%, 62.2% and 71.2%, respectively of spleno-portal index for diagnosing esophageal varices.
The pathophysiologic changes that accompany the process of cirrhosis could explain the usefulness of splenoportal index in predicting esophageal varix formation. Fibrosis in liver leads to increased portal resistance. This leads to stagnation of portal blood flow resulting in increased resistance to venous outflow from spleen. Consequently, congestive splenomegaly develops. Concomitantly, increased splanchnic inflow augments the splenomegaly and aggravates portal hypertension. The increase in portal hypertension facilitates esophageal varix formation as well as further augmenting the splenomegaly. 21 It is not surprising, therefore, that splenomegaly is common in cirrhosis. 22 Previous studies have also shown that decrease in mean portal vein velocity correlated with severity of portal hypertension and risk of bleeding from esophageal varices. 23 Splenoportal index incorporates both these parameters, i.e. splenic size as well as portal vein velocity. Therefore, it has been shown to be a useful non-invasive tool for diagnosis of esophageal varices.
In addition to its non-invasive nature, splenoportal index offers a couple of other advantages over other parameters. First, it can be concomitantly measured during routine biannual ultrasound screening for hepatocellular carcinoma in cirrhotic patients; hence, reducing additional costs. Secondly, it can be measured easily in outpatient setting unlike other biochemical tests and endocopy. So, it is recommended that Doppler ultrasonography should be routinely used for predicting presence of esophageal varices in cirrhosis rather than subjecting them to invasive endoscopy which should be reserved for therapeutic interventions.
This study differed from other similar studies in that the study population comprised of a relatively homogenous group consisting of patients having cirrhosis induced by chronic infection with hepatitis-C virus. While most of the subjects in the other studies also had hepatitis-C induced cirrhosis, there were subjects with cirrhosis due to other etiologies as well.
CONCLUSION
This study concluded that Doppler ultrasonography is the non-invasive modality of choice with high diagnostic accuracy in predicting presence of esophageal varices in patients with Hepatitis-C induced cirrhosis. It can help reduce the financial burden on health facilities as well as better compliance of patients as compared to endoscopy. These factors coupled with wider availability and requirement of lesser expertise further highlight its emerging role for this purpose.
